Nutex Health (NASDAQ:NUTX) Trading Up 8.2% – Here’s Why

Nutex Health Inc. (NASDAQ:NUTX)’s stock price was up 8.2% on Thursday . The stock traded as high as $185.33 and last traded at $186.65. 62,217 shares were traded during mid-day trading, a decline of 64% from the average session volume of 172,757 shares. The stock had previously closed at $172.45.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Zacks Research upgraded shares of Nutex Health to a “hold” rating in a research report on Monday, June 29th. B. Riley Financial began coverage on Nutex Health in a report on Friday, June 26th. They set a “buy” rating and a $290.00 price target on the stock. Wall Street Zen lowered Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Monday, July 20th. Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, July 28th. Finally, Lake Street Capital reaffirmed a “buy” rating and set a $310.00 target price (up from $235.00) on shares of Nutex Health in a research note on Tuesday. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $268.33.

Nutex Health Stock Performance

The stock has a market cap of $1.28 billion, a P/E ratio of 7.36 and a beta of 0.24. The company has a fifty day moving average of $162.37 and a 200 day moving average of $130.19. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 3.12.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings results on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. The firm had revenue of $210.75 million during the quarter, compared to analyst estimates of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. On average, equities analysts predict that Nutex Health Inc. will post 30.11 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Nutex Health

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Jupiter Topco LLC acquired a new position in shares of Nutex Health in the 2nd quarter valued at $221,000. Legal & General Group Plc acquired a new position in Nutex Health in the 2nd quarter worth approximately $671,000. The Manufacturers Life Insurance Company purchased a new position in Nutex Health during the 2nd quarter worth approximately $229,000. Winmill & CO. Inc. purchased a new stake in shares of Nutex Health in the second quarter valued at $11,168,000. Finally, Allworth Financial LP acquired a new stake in shares of Nutex Health in the second quarter worth $35,000. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight?loss services and behavioral health support. By combining in?person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost?effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail?anchored centers, offering treatment for non?life?threatening injuries and illnesses, preventive screenings and basic primary care.